BIA welcomes new NIHR framework for restarting research activities in the UK
Commenting on the NIHR 'Framework for restart' released today, Steve Bates OBE, Chief Executive of the BIA said:
"The National Institute for Health Research (NIHR) published today a ‘Framework for restart’, a guidance document to help sponsors planning to restart trials or to initiate new clinical trials which have been paused due to the COVID-19 pandemic, as well as to support local decision-making.
"The BIA would like to acknowledge the collaborative approach by the DHSC and the NIHR Coordinating Centres in the development of the Restart Framework to restore a fully active portfolio of NIHR research to improve the health and wealth of the nation, given the impact that paused studies have had for patient participants, BIA member companies and the life sciences sector."
Notes to Editors
1. For more information please contact Shannon Quinney, Communications Executive, on firstname.lastname@example.org or 07864 902930
2. The NIHR's Restart framework can be found here.
About the BIA
Established over 25 years ago at the infancy of biotechnology, the BioIndustry Association (BIA) is the trade association for innovative life sciences in the UK. Our goal is to secure the UK's position as a global hub and as the best location for innovative research and commercialisation, enabling our world-leading research base to deliver healthcare solutions that can truly make a difference to people's lives.